The Council decided to reduce the GST rate on cancer drugs Trastuzumab Deruxtecan, Osimertinib and Durvalumab from 12% to 5%. Related posts: Directive on swearing-in not followed, West Bengal Governor seeks Assembly’s response CD with essential topics on G.I. endoscopy launched in city LGBTQ persons can nominate a person in the queer relationship as a nominee for bank accounts: Ministry of Finance PM Modi lays foundation stone of Vadhvan Port project in Maharashtra’s Palghar
